Fasting-Associated Immune-metabolic Remission of Diabetes
FAIR
1 other identifier
interventional
52
1 country
1
Brief Summary
People with a body mass index above 28 kg/m² and an onset of type 2 diabetes within the last 4 years had a remission (HbA1c \<6.5% without medication) of diabetes in over 80% upon weight loss of 15 kg. Longer duration of diabetes reduced the chance of remission. The investigators will test whether there is a difference in remission upon weight loss of 15 kg using formula low calorie diets between subjects with a diabetes duration of \<4 years vs. \>8 years and oral treatment as primary end points. The immune metabolic programming of circulating monocytes will be investigated in detail regarding trained innate immunity and the endocrine responses will be determined using meal challenge tests.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable type-2-diabetes-mellitus
Started Sep 2020
Typical duration for not_applicable type-2-diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 25, 2020
CompletedStudy Start
First participant enrolled
September 25, 2020
CompletedFirst Posted
Study publicly available on registry
March 24, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2023
CompletedAugust 30, 2023
August 1, 2023
2.3 years
September 25, 2020
August 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Concentration of fasting blood glucose < 126 mg/deciliter
Remission of type 2 diabetes defined by a concentration of a fasting blood glucose \< 126 mg/deciliter without diabetes medication
3 month
Secondary Outcomes (2)
Immune-metabolic profile and programing of innate immunity
before, after 7 days and after 3 month
Composition of the microbiome
before, after 7 days and after 3 month
Study Arms (2)
type 2 diabetes - less than 4 years duration
OTHERPatients with a duration of less than 4 years since diagnosis of type 2 diabetes, BMI \> 28 kg/m², non-insulin treated who agree to loose 15 kg body weight by eating a very low calorie formula diet of 800 kcal/day for men and 600 kcal/day for women. The duration of the diet is until the weight loss is achieved.
type 2 diabetes - more than 8 years
OTHERPatients with a duration of more than 8 years since diagnosis of type 2 diabetes, BMI \> 28 kg/m², non-insulin treated who agree to loose 15 kg body weight by eating a very low calorie formula diet of 800 kcal/day for men and 600 kcal/day for women. The duration of the diet is until the weight loss is achieved.
Interventions
The anthropometric, endocrine and metabolic status is tested before, after 7 days and after 15 kg weight loss
Eligibility Criteria
You may qualify if:
- Type 2 diabetes diagnosed less than 4 or over 8 years, before study,
- BMI \> 28 kg/m²,
- willingness to follow weight loss diet,
You may not qualify if:
- consuming disease,
- intolerance for very low calorie formula diet,
- known severe hepatic disease or liver cirrhosis,
- type 1 diabetes,
- severe disease of kidney or heart,
- advanced diabetic retinopathy,
- intake of glucocorticoids,
- drug or alcohol abuse,
- weight loss of \>5 kg in the last 3 month,
- eating disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Charité Campus Benjamin Franklin
Berlin, 12203, Germany
Related Publications (2)
Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Peters C, Zhyzhneuskaya S, Al-Mrabeh A, Hollingsworth KG, Rodrigues AM, Rehackova L, Adamson AJ, Sniehotta FF, Mathers JC, Ross HM, McIlvenna Y, Stefanetti R, Trenell M, Welsh P, Kean S, Ford I, McConnachie A, Sattar N, Taylor R. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018 Feb 10;391(10120):541-551. doi: 10.1016/S0140-6736(17)33102-1. Epub 2017 Dec 5.
PMID: 29221645BACKGROUNDSteven S, Hollingsworth KG, Al-Mrabeh A, Avery L, Aribisala B, Caslake M, Taylor R. Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders. Diabetes Care. 2016 May;39(5):808-15. doi: 10.2337/dc15-1942. Epub 2016 Mar 21.
PMID: 27002059BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Andreas FH Pfeiffer, MD
Universitätsmedizin Berlin CBF
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Professor
Study Record Dates
First Submitted
September 25, 2020
First Posted
March 24, 2022
Study Start
September 25, 2020
Primary Completion
December 31, 2022
Study Completion
April 30, 2023
Last Updated
August 30, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share